Blau Farmacêutica S.A. (BVMF:BLAU3)

Brazil flag Brazil · Delayed Price · Currency is BRL
12.79
-0.69 (-5.12%)
Dec 5, 2025, 5:40 PM GMT-3
-5.26%
Market Cap 2.40B
Revenue (ttm) 1.77B
Net Income (ttm) 324.56M
Shares Out 177.68M
EPS (ttm) 1.82
PE Ratio 7.40
Forward PE 7.81
Dividend 0.36 (2.70%)
Ex-Dividend Date Dec 5, 2025
Volume 516,500
Average Volume 279,320
Open 13.50
Previous Close 13.48
Day's Range 12.73 - 13.50
52-Week Range 11.48 - 14.76
Beta 0.40
RSI 66.30
Earnings Date Feb 20, 2026

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics... [Read more]

Sector Healthcare
Founded 1987
Employees 1,900
Stock Exchange Brazil Stock Exchange
Ticker Symbol BLAU3
Full Company Profile

Financial Performance

In 2024, Blau Farmacêutica's revenue was 1.75 billion, an increase of 27.81% compared to the previous year's 1.37 billion. Earnings were 217.21 million, a decrease of -13.05%.

Financial Statements

News

There is no news available yet.